Humboldt Fund
Humboldt Fund is a New York-based private investment firm with 1-10 employees that targets bio revolution companies. Founded by Benjamin Quiroga, the firm maintains a minimal public footprint with no disclosed portfolio, fund size, or operational details beyond its name, logo, and stated sector focus.
- Company typePrivate
- Founded-
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Humboldt Fund does
Humboldt Fund is a privately-held investment firm headquartered in New York, United States. Per available firmographic data, the firm focuses on investing in companies operating within the "bio revolution" sector, indicating a thesis-driven mandate oriented toward biology-adjacent and life-sciences ventures. The firm operates with a small team of 1-10 employees, consistent with an emerging or early-stage venture capital structure. Benjamin Quiroga is identified as the founder and co-founder.
The firm's public footprint is minimal. Its website (humboldtfund.com) currently displays only the company name, the word "Humboldt," and a logo, with no disclosed portfolio companies, fund size, investment stage focus, sector thesis detail, team page, or contact information beyond the founder reference. No app, API, integrations, or technology products are associated with the firm in the source data. The "doing business as" name in the source material is listed simply as "Humboldt," with no sub-brands or prior names disclosed.
No revenue, AUM, fund vintage, capital commitments, LP base, partnerships, awards, regulatory actions, or M&A activity are documented in the available data. There are no disclosed funding rounds, parent entities, subsidiaries, or office locations beyond the New York headquarters. The combination of a 1-10 employee headcount, a logo-only website, and the absence of any disclosed portfolio or fund vehicle in the source material indicates either a fund in early formation, a recently launched vehicle that has not yet publicly deployed capital, or a deliberately low-profile operation. Any further characterization of fund mechanics, investment cadence, or capital structure would exceed what the source data supports.
Humboldt Fund firmographics
Firmographics- Name
- Humboldt Fund
- Website
- https://humboldtfund.com
- Company type
- Private
- Headcount range
- 1–10 employees
- Short description
- Humboldt Fund is a New York-based private investment firm with 1-10 employees that targets bio revolution companies. Founded by Benjamin Quiroga, the firm maintains a minimal public footprint with no disclosed portfolio, fund size, or operational details beyond its name, logo, and stated sector focus.
- Ownership category
- akta.pro rank
Humboldt Fund industry classification
Industry- Product category
- Venture Capital / Bio-focused Investment
- NAICS
- Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282), Investors, Nec (6799)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industry
- SDG / Thematic Sustainable Investment Funds (FSANAJAN)
Keywords
Where Humboldt Fund is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Humboldt Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Humboldt Fund product offering
Product offeringCore offering
Humboldt Fund is an investment firm that deploys capital into bio revolution companies. Its core offering is venture/private investment exposure to biology-driven businesses, with the firm operating as a small, founder-led vehicle headquartered in New York.
Product overview
The source data provides only minimal information about Humboldt Fund - a homepage displaying the company name and logo. No product or service details are available in the provided content.
Differentiator
Problem solved
Functional benefit
Products and services
- Humboldt Fund (Investment Vehicle) Humboldt Fund is an investment vehicle that deploys capital into bio revolution companies. It is designed for investors seeking venture capital exposure to biology-driven businesses, and for bio revolution companies seeking venture capital funding.
Companies that use Humboldt Fund
Customer profileIdeal customer profiles1 record
Humboldt Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Humboldt Fund partnerships and signals
Strategic signalRecent moves2 records
Humboldt Fund competitors and assessment
Company assessmentEmerging players
- Y Combinator: YC funds a growing share of bio and synbio startups through its standard accelerator and dedicated bio track, providing comparable early-stage exposure to bio revolution companies though via an accelerator model rather than a thesis fund.
Direct peers
- ARCH Venture Partners: ARCH is a leading early-stage venture firm focused on biotech, advanced materials, and deep tech — directly comparable to Humboldt's bio revolution mandate, though operating at significantly greater scale and with longer track record.
- Flagship Pioneering: Flagship originates and funds bio-platform companies (e.g., Moderna), making it the closest thematic peer to a fund investing in bio revolution companies — both target the same convergence of biology and technology.
- Lux Capital: Lux Capital invests at the intersection of science, technology, and biology, with a portfolio spanning synbio, neurotech, and frontier bio — making it a strong thematic peer to a bio-revolution-focused fund.
- Khosla Ventures: Khosla invests aggressively across bio, synbio, health, and deep tech from seed onward — a directly comparable thesis-driven early-stage investor in bio revolution companies.
- Breakout Ventures: Breakout Ventures funds early-stage companies at the intersection of biology and technology, making it a directly comparable early-stage bio-focused peer.
- Civilization Ventures: Civilization Ventures invests in health, biotech, and technology platforms — a directly comparable emerging bio-focused venture firm at similar early stage.
- Section32: Section32 is a venture fund specifically focused on health, biotech, and digital health — directly comparable to Humboldt's bio-thesis focus area.
- Digitalis Ventures: Digitalis Ventures invests at the intersection of biology, engineering, and computation — directly comparable thematic peer for a fund targeting the bio revolution.
Broad incumbents
- Andreessen Horowitz (a16z Bio Fund): a16z operates a dedicated Bio + Health fund investing across bio, digital health, and therapeutics — a broad incumbent with overlapping bio-thesis exposure though part of a much larger multi-stage platform.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Humboldt Fund social profiles
Digital presenceHumboldt Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
Humboldt Fund leadership team
Management profileNumber of profiles
Profiles1 record
Humboldt Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Humboldt Fund M&A and investment
M&A and investmentM&A
Investments26 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Humboldt Fund
What does Humboldt Fund do?
Humboldt Fund is an investment firm that deploys capital into bio revolution companies. Its core offering is venture/private investment exposure to biology-driven businesses, with the firm operating as a small, founder-led vehicle headquartered in New York.
When was Humboldt Fund founded?
Humboldt Fund was founded in -1. It employs 1 to 10 people.
Where is Humboldt Fund based?
Humboldt Fund is headquartered in New York, United States, in the North America region.
Who are Humboldt Fund's main competitors?
Y Combinator is listed as an emerging player. Direct peers are ARCH Venture Partners, Flagship Pioneering, Lux Capital, Khosla Ventures, Breakout Ventures, Civilization Ventures, Section32 and Digitalis Ventures. Andreessen Horowitz (a16z Bio Fund) is listed as a broad incumbent.
Does Humboldt Fund have an API?
No public API is recorded for Humboldt Fund.
What industry is Humboldt Fund in?
Humboldt Fund's product category is Venture Capital / Bio-focused Investment. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAJAN, SDG / Thematic Sustainable Investment Funds. Its NAICS code is 5259 and its SIC code is 6282.